AxoSim’s Director of Scientific Operations, Megan Terral, gave an oral presentation at the 2nd annual ADC Toxicity Summit titled “High-throughput Functional and Morphological Neurotoxicity Screening in Human NerveSim®.” The summit, which took place July 23-25 in Boston, is the only ADC event that purely focuses on improving the prediction and translation of ADC toxicities from preclinical studies to the clinic.
AxoSim was proud to sponsor and present alongside leading minds in ADC toxicology and engage in in-depth conversations to make meaningful strides forward in developing safer ADCs, advance them to clinic, and improve patient outcomes. Click the thumbnail below to view the poster associated with Megan’s presentation.
